Virulence and drug resistance in malaria parasites

Trends in Parasitology

Volumn 25, Issue 10, 2009, Pages 441-443

  Stein, Wilfred D ^a   Sanchez, Cecilia P ^b   Lanzer, Michael ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; PYRIMETHAMINE;

BIOSYNTHESIS; CELL DIVISION; COEVOLUTION; DRUG SENSITIVITY; HUMAN; NONHUMAN; PHARMACOGENETICS; PLASMODIUM; PLASMODIUM CHABAUDI INFECTION; SHORT SURVEY; VIRULENCE;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; FOLIC ACID; MULTIENZYME COMPLEXES; PARASITIC SENSITIVITY TESTS; PLASMODIUM; PYRIMETHAMINE; TETRAHYDROFOLATE DEHYDROGENASE; THYMIDYLATE SYNTHASE; VIRULENCE;

EID: 70149096866     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2009.07.003     Document Type: Short Survey

References (23)

1. Snow R.W., et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (2005) 214-217
2. Mita T., et al. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am. J. Trop. Med. Hyg. 68 (2003) 413-415
3. Mita T., et al. Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol. Biochem. Parasitol. 135 (2004) 159-163
4. Wang X., et al. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Am. J. Trop. Med. Hyg 72 (2005) 410-414
5. Kublin J.G., et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187 (2003) 1870-1875
6. Hayward R., et al. pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol. Microbiol. 55 (2005) 1285-1295
7. Shinondo C.J., et al. Effect of pyrimethamine resistance on sporogony in a Plasmodium berghei / Anopheles stephensi model. Exp. Parasitol. 78 (1994) 194-202
8. Rosario V.E., et al. Persistence of drug-resistant malaria parasites. Lancet 1 (1978) 185-187
9. Schneider P., et al. Does the drug sensitivity of malaria parasites depend on their virulence?. Malar J. 7 (2008) 257
10. Mackinnon M.J., et al. Virulence in rodent malaria: host genotype by parasite genotype interactions. Infect. Genet. Evol. 1 (2002) 287-296
11. Ekland E.H., and Fidock D.A. Advances in understanding the genetic basis of antimalarial drug resistance. Curr. Opin. Microbiol. 10 (2007) 363-370
12. Mita T., et al. Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa. J. Antimicrob. Chemother. 63 (2009) 252-255
13. Abali E.E., et al. Regulation of human dihydrofolate reductase activity and expression. Vitam. Horm. 79 (2008) 267-292
14. Thaithong S., et al. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine. Exp. Parasitol. 98 (2001) 59-70
15. Dharia N.V., et al. Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum. Genome Biol. 10 (2009) R21
16. Sanchez C.P., et al. Dissecting the components of quinine accumulation in Plasmodium falciparum. Mol. Microbiol. 67 (2008) 1081-1093
17. Sanchez C.P., et al. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum. Trends Parasitol. 23 (2007) 332-339
18. Valderramos S.G., and Fidock D.A. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol. Sci. 27 (2006) 594-601
19. Borges-Walmsley M.I., et al. Structure and function of efflux pumps that confer resistance to drugs. Biochem. J. 376 (2003) 313-338
20. Litman T., et al. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life. Sci 58 (2001) 931-959
21. Jansen G., et al. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J. Biol. Chem. 273 (1998) 30189-30198
22. Assaraf Y.G., and Goldman I.D. Loss of folic acid exporter function with markedly augmented folate accumulation in lipophilic antifolate-resistant mammalian cells. J. Biol. Chem. 272 (1997) 17460-17466
23. Martin R.E., et al. The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum. Genome Biol. 6 (2005) R26